JNJ Johnson & Johnson

  1. Stocks
  2. Healthcare
  3. NYSE: JNJ

Price (delayed)

$270.56

Market cap

$651.32B

P/E Ratio

40.5

Dividend/share

$5.28

EPS

$6.68

Enterprise value

$679.06B

?
Relative Growth: Rel. Growth: 48
Relative Strength: Rel. Strength: 78
Relative Valuation: Rel. Valuation: 19
Relative Profitability: Rel. Profitability: 77

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments ...

Highlights
Johnson & Johnson's debt has decreased by 9% from the previous quarter and by 2.5% YoY
JNJ's revenue is up by 8% year-on-year
JNJ's equity is down by 4.1% since the previous quarter but it is up by 2.8% year-on-year
JNJ's price to earnings (P/E) is 82% higher than its 5-year quarterly average of 22.3 and 40% higher than its last 4 quarters average of 29.0
The EPS has contracted by 36% YoY and by 23% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.jnj.com
Peers: PFE MRK NVS SYK

Key stats

What are the main financial stats of JNJ

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
-0.97%
1 week
1.6%
1 month
5.68%
1 year
43.25%
YTD
30.74%
QTD
2.2%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$99.34B
Gross profit
$67.11B
Operating income
$24.74B
Net income
$16.1B
Gross margin
67.6%
Net margin
16.2%
Johnson & Johnson's net margin has decreased by 41% YoY and by 25% from the previous quarter
Johnson & Johnson's net income has decreased by 36% YoY and by 23% QoQ
JNJ's revenue is up by 8% year-on-year
The gross profit is up by 7% YoY

Price vs fundamentals

How does JNJ's price correlate with its fundamentals

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
JNJ P/E details
P/E
40.5
P/B
8
P/S
6.56
EV/EBIT
36.27
EV/EBITDA
25.33
EV/Sales
6.84
JNJ's price to earnings (P/E) is 82% higher than its 5-year quarterly average of 22.3 and 40% higher than its last 4 quarters average of 29.0
The EPS has contracted by 36% YoY and by 23% from the previous quarter
JNJ's price to book (P/B) is 36% more than its 5-year quarterly average of 5.9 and 13% more than its last 4 quarters average of 7.1
JNJ's equity is down by 4.1% since the previous quarter but it is up by 2.8% year-on-year
The price to sales (P/S) is 26% more than the 5-year quarterly average of 5.2 and 9% more than the last 4 quarters average of 6.0
JNJ's revenue is up by 8% year-on-year

Efficiency

How efficient is Johnson & Johnson business performance
Johnson & Johnson's return on invested capital has decreased by 48% YoY and by 29% QoQ
The ROS has contracted by 47% YoY and by 30% from the previous quarter
The company's return on equity fell by 40% YoY and by 24% QoQ
The return on assets has declined by 39% year-on-year and by 24% since the previous quarter

Dividends

What is JNJ's dividend history
Dividend details
DPS
$5.28
Dividend yield
1.95%
Payout ratio
79%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 70% greater than its total liabilities
The quick ratio has decreased by 11% QoQ and by 8% YoY
JNJ's current ratio is down by 6% since the previous quarter and by 4.7% year-on-year
Johnson & Johnson's debt is 45% less than its equity
Johnson & Johnson's debt has decreased by 9% from the previous quarter and by 2.5% YoY
The company's debt to equity fell by 5% QoQ and by 5% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.